FDA Advisory Committee to Review ISTA Pharma's (ISTA) NDA for Bepreve(TM)
Tweet Send to a Friend
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced it has received notification from the U.S. FDA that the Dermatologic and Ophthalmic ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
